Engineering subtilisin proteases that specifically degrade active RAS
Autor: | John Orban, Yihong Chen, Yanan He, David J. Weber, Eun Jung Choi, Raquel Godoy-Ruiz, Biao Ruan, D. Travis Gallagher, Melani Solomon, Thomas R. Fuerst, Ruixue Wang, David A. Rozak, Gregory S. Custer, Philip N. Bryan, Harlan King, Silvia Muro, Eric A. Toth, Yingwei Chen, Richard Simmerman |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Models
Molecular Proteases Magnetic Resonance Spectroscopy QH301-705.5 medicine.medical_treatment Proteolysis Medicine (miscellaneous) Protein Engineering Article General Biochemistry Genetics and Molecular Biology Cofactor Substrate Specificity Conserved sequence Proto-Oncogene Proteins p21(ras) 03 medical and health sciences 0302 clinical medicine medicine Humans Biology (General) X-ray crystallography 030304 developmental biology 0303 health sciences Cofactor binding Protease biology medicine.diagnostic_test Chemistry Subtilisin Active site Cell biology Kinetics HEK293 Cells 030220 oncology & carcinogenesis biology.protein Protein design General Agricultural and Biological Sciences |
Zdroj: | Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021) Communications Biology |
ISSN: | 2399-3642 |
Popis: | We describe the design, kinetic properties, and structures of engineered subtilisin proteases that degrade the active form of RAS by cleaving a conserved sequence in switch 2. RAS is a signaling protein that, when mutated, drives a third of human cancers. To generate high specificity for the RAS target sequence, the active site was modified to be dependent on a cofactor (imidazole or nitrite) and protease sub-sites were engineered to create a linkage between substrate and cofactor binding. Selective proteolysis of active RAS arises from a 2-step process wherein sub-site interactions promote productive binding of the cofactor, enabling cleavage. Proteases engineered in this way specifically cleave active RAS in vitro, deplete the level of RAS in a bacterial reporter system, and also degrade RAS in human cell culture. Although these proteases target active RAS, the underlying design principles are fundamental and will be adaptable to many target proteins. Chen et al. describe a rational design of subtilisin mutants that degrade active RAS by cleaving a conserved sequence in switch 2. They further modified the active site to be dependent on a cofactor to generate high target specificity. Proteases engineered to cleave this region degraded RAS in vitro and in cells with a promise of adaptability for other target proteins too. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |